XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Summary information by reportable business segment Summary information by reportable business segment is as follows (dollars in thousands):
For the Three Months Ended September 30, 2023
SHOPOutpatient Medical and Research PortfolioTriple-Net
Leased
Properties		Non-SegmentTotal
Revenues:     
Rental income$— $226,326 $159,812 $— $386,138 
Resident fees and services754,417 — — — 754,417 
Third party capital management revenues— 662 — 4,653 5,315 
Income from loans and investments— — — 1,208 1,208 
Interest and other income— — — 2,754 2,754 
Total revenues$754,417 $226,988 $159,812 $8,615 $1,149,832 
Total revenues$754,417 $226,988 $159,812 $8,615 $1,149,832 
Less:     
Interest and other income— — — 2,754 2,754 
Property-level operating expenses573,715 78,915 3,847 — 656,477 
Third party capital management expenses— — — 1,4721,472 
NOI$180,702 $148,073 $155,965 $4,389 489,129 
Interest and other income    2,754 
Interest expense    (147,919)
Depreciation and amortization    (370,377)
General, administrative and professional fees    (33,297)
Loss on extinguishment of debt, net(612)
Transaction expenses and deal costs    (7,125)
Allowance on loans receivable and investments66 
Other    (9,432)
Loss from unconsolidated entities(5,119)
Gain on real estate dispositions10,711 
Income tax benefit    1,662 
Loss from continuing operations    (69,559)
Net loss(69,559)
Net income attributable to noncontrolling interests1,565 
Net loss attributable to common stockholders$(71,124)
For the Three Months Ended September 30, 2022
SHOPOutpatient Medical and Research PortfolioTriple-Net
Leased
Properties		Non-SegmentTotal
Revenues:     
Rental income$— $200,867 $150,115 $— $350,982 
Resident fees and services668,583 — — — 668,583 
Third party capital management revenues— 547 — 4,003 4,550 
Income from loans and investments— — — 12,672 12,672 
Interest and other income— — — 489 489 
Total revenues$668,583 $201,414 $150,115 $17,164 $1,037,276 
Total revenues$668,583 $201,414 $150,115 $17,164 $1,037,276 
Less:     
Interest and other income— — — 489 489 
Property-level operating expenses499,972 66,098 3,756 — 569,826 
Third party capital management expenses— — — 1,750 1,750 
NOI$168,611 $135,316 $146,359 $14,925 465,211 
Interest and other income    489 
Interest expense    (119,413)
Depreciation and amortization    (301,481)
General, administrative and professional fees    (35,421)
Loss on extinguishment of debt, net(574)
Transaction expenses and deal costs    (4,782)
Allowance on loans receivable and investments63 
Other    (9,162)
Income from unconsolidated entities1,970 
Gain on real estate dispositions136 
Income tax benefit    6,027 
Income from continuing operations    3,063 
Net income3,063 
Net income attributable to noncontrolling interests1,807 
Net income attributable to common stockholders$1,256 
For the Nine Months Ended September 30, 2023
SHOPOutpatient Medical and Research PortfolioTriple-Net
Leased
Properties		Non-SegmentTotal
Revenues:     
Rental income$— $645,137 $463,906 $— $1,109,043 
Resident fees and services2,184,024 — — — 2,184,024 
Third party capital management revenues— 1,849 — 11,639 13,488 
Income from loans and investments— — — 21,351 21,351 
Interest and other income— — — 5,529 5,529 
Total revenues$2,184,024 $646,986 $463,906 $38,519 $3,333,435 
Total revenues$2,184,024 $646,986 $463,906 $38,519 $3,333,435 
Less:     
Interest and other income— — — 5,529 5,529 
Property-level operating expenses1,658,047 217,999 11,180 — 1,887,226 
Third party capital management expenses— — — 4,614 4,614 
NOI$525,977 $428,987 $452,726 $28,376 1,436,066 
Interest and other income    5,529 
Interest expense    (419,259)
Depreciation and amortization    (957,185)
General, administrative and professional fees    (112,494)
Gain on extinguishment of debt, net6,189 
Transaction expenses and deal costs    (11,580)
Allowance on loans receivable and investments20,195 
Gain on foreclosure of real estate29,127 
Other    765 
Income from unconsolidated entities20,512 
Gain on real estate dispositions22,317 
Income tax benefit    14,237 
Income from continuing operations54,419 
Net income54,419 
Net income attributable to noncontrolling interests4,573 
Net income attributable to common stockholders    $49,846 
For the Nine Months Ended September 30, 2022
SHOPOutpatient Medical and Research PortfolioTriple-Net
Leased
Properties		Non-SegmentTotal
Revenues:     
Rental income$— $600,648 $451,073 $— $1,051,721 
Resident fees and services1,977,760 — — — 1,977,760 
Third party capital management revenues— 1,834 — 10,991 12,825 
Income from loans and investments— — — 33,271 33,271 
Interest and other income— — — 2,191 2,191 
Total revenues$1,977,760 $602,482 $451,073 $46,453 $3,077,768 
Total revenues$1,977,760 $602,482 $451,073 $46,453 $3,077,768 
Less:     
Interest and other income— — — 2,191 2,191 
Property-level operating expenses1,482,948 192,609 11,349 — 1,686,906 
Third party capital management expenses— — — 4,473 4,473 
NOI$494,812 $409,873 $439,724 $39,789 1,384,198 
Interest and other income    2,191 
Interest expense    (344,158)
Depreciation and amortization    (873,620)
General, administrative and professional fees    (111,334)
Loss on extinguishment of debt, net(581)
Transaction expenses and deal costs    (37,852)
Allowance on loans receivable and investments179 
Other    (30,088)
Loss from unconsolidated entities(3,346)
Gain on real estate dispositions2,557 
Income tax benefit    14,307 
Income from continuing operations    2,453 
Net income2,453 
Net income attributable to noncontrolling interests4,881 
Net loss attributable to common stockholders$(2,428)
Reconciliation of Assets from Segment to Consolidated
Capital expenditures, including investments in real estate property and development project expenditures, by reportable business segment are as follows (dollars in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2023202220232022
Capital Expenditures:
SHOP$99,115 $114,453 $254,795 $313,396 
Outpatient medical and research portfolio62,455 44,150 143,073 403,976 
Triple-net leased properties1,006 1,268 6,765 3,676 
Total capital expenditures$162,576 $159,871 $404,633 $721,048 
Revenues from external customers by geographic area Geographic information regarding our operations is as follows (dollars in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2023202220232022
Revenues:
United States$1,025,544 $918,106 $2,967,419 $2,719,097 
Canada116,926 112,550 344,372 337,503 
United Kingdom7,362 6,620 21,644 21,168 
Total revenues$1,149,832 $1,037,276 $3,333,435 $3,077,768 

As of September 30, 2023As of December 31, 2022
Net Real Estate Property:
United States$19,110,447 $18,168,224 
Canada2,775,041 2,782,350 
United Kingdom203,293 209,876 
Total net real estate property$22,088,781 $21,160,450